Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs)-an enzyme family that deacetylates histones and non-histone proteins-are implicated in human diseases such as cancer, and the first-generation of HDAC inhibitors are now in clinical trials. Here, we report the 2.0 A resolution crystal structure of a catalytically inactive HDAC8 active-site mutant, Tyr306Phe, bound to an acetylated peptidic substrate. The structure clarifies the role of active-site residues in the deacetylation reaction and substrate recognition. Notably, the structure shows the unexpected role of a conserved residue at the active-site rim, Asp 101, in positioning the substrate by directly interacting with the peptidic backbone and imposing a constrained cis-conformation. A similar interaction is observed in a new hydroxamate inhibitor-HDAC8 structure that we also solved. The crucial role of Asp 101 in substrate and inhibitor recognition was confirmed by activity and binding assays of wild-type HDAC8 and Asp101Ala, Tyr306Phe and Asp101Ala/Tyr306Phe mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, D94 corresponds to acetyllysine binding residues D101 of hHDAC8 and S568 of hHDAC6 CD2 (refs 17, 30, 31).”
From Histone deacetylase 10 structure and molecular function as a polyamine deacetylase (2017) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In HDAC8, highly conserved D101 accepts hydrogen bonds from the two backbone amide groups flanking the scissile acetyllysine residue.37,38”
From Histone deacetylase 6 structure and molecular basis of catalysis and inhibition (2016) · cites this paper as [37]
In the citing paper
“Crystal structures of human HDAC8, in complex with different inhibitors, have been reported; they revealed a single α/β-domain with a core eight-stranded parallel β-sheet and 11 α-helices.7, 31, 32”
From HDAC8 catalyzes the hydrolysis of long chain fatty acyl lysine (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742 · cited 1×
“Model building was carried out using QUANTA2000 (Accelrys, Cambridge, UK) and refinement with REFMAC (Murshudov et al, 1997).”
MethodPRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845 · cited 1×
“Acetylation status of the lysine residue at the N-terminal extensions of core histones is controlled by two counteracting enzymes: histone acetyl transferases and histone deacetylases (HDACs; Roth et al, 2001; Marks et al, 2003).”
BackgroundStructures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 6×
“The HDAC8 active site (Somoza et al, 2004; Vannini et al, 2004) presents features of both serine and zinc proteases, and contains two His–Asp dyads with both histidine residues supposed to work as a general acid–base catalytic pair, as originally proposed for HDLP and extended to HDAH (Finnin et al, 1999; Nielsen et a…”
BackgroundResultInfluentialThe Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495 · cited 1×
“HDAC11 is distinct from those in classes I and II; therefore, it has been placed in class IV, as class III refers to the unrelated sirtuin deacetylases (Blander & Guarente, 2004).”
BackgroundGregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456 · cited 1×
“Eukaryotic HDACs have been classified into four groups on the basis of phylogenetic analysis (Gregoretti et al, 2004).”
Backgroundp53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage
Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · cited 2×
“whereas the substrate has no coumarin group, substituted instead with Leu-Met and corresponding to p53 protein sequence 379–384 (Liu et al, 1999).”
BackgroundFischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754 · cited 1×
“The only significant exception is Tyr306, which is histidine in class IIa HDACs (4, 5, 7, 9), which causes a pronounced decrease in catalytic activity on peptidic substrates (Fischle et al, 2002).”
BackgroundStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · cited 1×
“As these processes are modulated during malignant transformation, HDAC inhibitors are being developed as antineoplastic drugs (Gallinari et al, 2007), and vorinostat was recently approved by the Food and Drug Administration for the treatment of cutaneous T-cell lymphoma.”
BackgroundSelf-citation
Cited by
Items 201–284 of 284
Wood, D. J., Tsvetkov, E., Comte‐Walters, S., Welsh, C. L., Bloyd, M., Wood, T. G., Akiki, R. M., Anderson, E. M., Penrod, R. D., Madan, L. K., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.027 · Cited by 8
“Our modeling of HDAC5’s 3D structure suggests that a disulfide bond between C696 and C698 may facilitate catalytic activity by increasing the proximity of acetylated substrate to amino acid D789— a critical residue thought to guide substrate to the catalytic pocket (43).”
Liu, H., Zhang, F., Wang, K., Tang, X., & Wu, R. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp02261a · Cited by 6
Du, J., Li, W., Liu, B., Zhang, Y., Yu, J., Hou, X., & Fang, H. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115607 · Cited by 6
“Crystal structures of HDAC8 with a fluorescent substrate (AMC substrate) have been determined[20] [21], and both of these structures indicate a dimeric arrangement in which the coumarin group of the substrates exhibit head-to-head packing (Fig.”
BackgroundMethodHistone Deacetylase Inhibitors
JONES, P. G. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627073.ch9 · Cited by 7
Self-citationMeyners, C., Krämer, A., Yıldız, Ö., & Meyer‐Almes, F. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.04.001 · Cited by 5
“This may be attributed to D101 in HDAHpa, which corresponds to D101 in HDAC8 and most other human HDACs that is essential for substrate recognition; substitution of D101 by alanine in HDAC8 renders the enzyme inactive [8].”
BackgroundPietra, F. (2015) · Chemistry & Biodiversity · doi:10.1002/cbdv.201400314 · Cited by 5
Kim, S., Lee, Y., Kim, S., Lee, S. J., Heo, P. K., Kim, S., Kwon, Y. J., & Lee, K. W. (2018) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.11366 · Cited by 6
Lysine Deacetylase Substrate Selectivity: A Dynamic Ionic Interaction Specific to KDAC8
Toro, T. B., Swanier, J. S., Bezue, J. A., Broussard, C. G., & Watt, T. J. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00384 · Cited by 5
Molecular Structure and Function of Zinc-Dependent Histone Deacetylases
Christianson, D. W. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051424-053005 · Cited by 5
Kurapati, C., Paidikondala, K., Badavath, V. N., Parveen, S., Singh, O. V., & Gundla, R. (2022) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4538 · Cited by 4
Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
Yusif, M. M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100097 · Cited by 5
Toro, T. B., Bornes, K. E., & Watt, T. J. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00001 · Cited by 4
Kollár, J., & Frecer, V. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.08.008 · Cited by 4
Optimal Substrate‐Trapping Mutants to Discover Substrates of HDAC1
Gomes, I. D., & Pflum, M. K. H. (2019) · ChemBioChem · doi:10.1002/cbic.201800797 · Cited by 4
Zang, X., Peraro, L., Davison, R. T., Blum, T. R., Vallabhaneni, D., Fennell, C. E., Cramer, S. L., Shah, H., Wholly, D. M., Fink, E. A., et al. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c00854 · Cited by 4
Ukey, S., Choudhury, C., & Sharma, P. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00197-9 · Cited by 4
Genetic Function Approximation and Bayesian Models for the Discovery of Future HDAC8 Inhibitors
Thangapandian, S., John, S., & Keun Woo, L. (2011) · Interdisciplinary Bio Central · doi:10.4051/ibc.2011.3.4.0015 · Cited by 3
Classification of HDAC8 Inhibitors and Non-Inhibitors Using Support Vector Machines
Cao, G. P., Thangapandian, S., John, S., & Lee, K. (2012) · Interdisciplinary Bio Central · doi:10.4051/ibc.2012.4.1.0002 · Cited by 4
Structural Biology of Epigenetic Targets
Romier, C., Wurtz, J., Renaud, J., & Cavarelli, J. (2009) · Methods and principles in medicinal chemistry · doi:10.1002/9783527627073.ch2 · Cited by 4
Karunanithy, G., Shukla, V. K., & Hansen, D. F. (2023) · doi:10.1101/2023.09.15.557823 · Cited by 4
Alrouji, M., Venkatesan, K., Alshammari, M. S., Alhumaydhi, F. A., Shafi, S., Sharaf, S. E., Shahwan, M. J., & Shamsi, A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1488585 · Cited by 4
Deacetylation mechanism of histone deacetylase 8: insights from QM/MM MP2 calculations
Lai, R., & Li, H. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp00002e · Cited by 4
Kim, B., Kantha, C., Kang, W., Jayaprakash, N., & Chung, H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118192 · Cited by 3
Histone Deactylase Inhibitors as Novel Target for Cancer, Diabetes, and Inflammation
Singh, P., & Madhavan, T. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.1.057 · Cited by 3
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Sehr, P. A., Gunkel, N., Miller, A. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12440096.v3 · Cited by 2
A small molecule PTER-selective inhibitor reduces food intake and body weight
Fu, S., Wang, L., Li, V. L., Lyu, X., Wei, W., Shi, X., Deng, S., Barber, J. L., Tahir, U. A., Adams, C., et al. (2026) · Cell Chemical Biology · doi:10.1016/j.chembiol.2026.02.005 · Cited by 2
Long, N., Meyer‐Almes, F., Kopranovic, A., & Wren, S. P. (2026) · ChemMedChem · doi:10.1002/cmdc.70270 · Cited by 2
“…carbonyl oxygen atom of the squaric acid core coordinates directly with the catalytic Zn 2 + ion, while the second carbonyl forms hydrogen bonds with His143 and Tyr306, generating a chelation motif analogous to the biden-tate coordination seen in hydroxamate-based inhibitors such as SAHA [60, 61].”
Nonradioactive In Vitro Assays for Histone Deacetylases
Hauser, A., Gajer, J. M., & Jung, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-305-3_17 · Cited by 2
Use of QM/DMD as a Multiscale Approach to Modeling Metalloenzymes
Gallup, N. M., & Alexandrova, A. N. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.05.018 · Cited by 2
“Here, we are going to select the PDB structure 2V5W, which was published in 2007 (Vannini et al., 2007) and has a resolution of 2.0 Å.”
MethodInfluentialCurrent perspective of histone deacetylase inhibitors: A review
Gharia, B. K., Upadhyay, J., Suhagia, B. N., & Shah, S. A. (2018) · International Journal of Pharmaceutical Chemistry and Analysis · doi:10.18231/2394-2797.2018.0018 · Cited by 3
Porter, N. J., & Christianson, D. W. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.06.029 · Cited by 2
Histone Deacetylase Inhibitors
Finn, P. W. (2009) · Wiley eBooks · doi:10.1002/9780470508169.ch35 · Cited by 2
Derwish, R. (2019) · Memorial University Research Repository (Memorial University) · Cited by 2
A small molecule PTER-selective inhibitor reduces food intake and body weight
Fu, S., Wang, L., Li, V. L., Lyu, X., Wei, W., Shi, X., Deng, S., Barber, J. L., Tahir, U. A., Adams, C., et al. (2026) · doi:10.64898/2026.01.26.701829 · Cited by 2
“1E,F ) resembles that of the translocation of protein acetyl-lysine side chains into the buried active site of HDACs 11,12 ( Fig.”
Oda, A., Kato, K., Morino, M., Nakayoshi, T., Fukuyoshi, S., Saijo, K., Ishioka, C., & Kurimoto, E. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1136/1/012019 · Cited by 3
Ramírez, J. E. G., & Mancilla, T. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14323 · Cited by 1
“…acetyl groups of the ε - amino groups of the lysine residues of the histones that form the chromatin resulting in packing of the structure and preventing gene transcription and causing gene silencing, reversibly regulated by histone acetyltransferases (HATs) (Gallinari et al., 2007; Struhl, 1998).”
BackgroundHigh-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach
Gerges, A., & Canning, U. (2025) · Molecules · doi:10.3390/molecules30102211 · Cited by 1
“Two compounds, 8b and 20a [15], and two receptors, 2V5X and 2V5W [16], were selected for this target (see Table 1).”
Investigation of the histone deacetylase inhibitor potential of phorbazole analogues
Reierth, I. A. N., Guttormsen, Y., Andersen, J. H., Hansen, E. H., Abdelhady, A. M., Langer, M. K., Haug, B. E., Bayer, A., & Petit, G. A. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118489 · Cited by 1
Garcia-Franco, P. M., Falcó-Martí, F. J., Jeblaoui, H., del Rio, M. A., Ortega-Alarcón, D., Vega, S., Galano-Frutos, J. J., Abián, O., & Velázquez‐Campoy, A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149851 · Cited by 1
Nováková, Z., Bartošová‐Sojková, P., Kudlacova, J., Baselious, F., Kutil, Z., Jaklová, P., Meleshin, M., Motlova, L., Schenkmayerová, A., Vrkoslav, V., et al. (2026) · Molecular Biology and Evolution · doi:10.1093/molbev/msag150 · Cited by 1
Searching Histone Deacetylase Inhibitors under Computational Procedures
Zacarías-Lara, O., González‐Juárez, D. E., & Correa‐Basurto, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802808-7.00007-1 · Cited by 1
Ononye, S. N. (2013) · OpenCommons at University of Connecticut (University of Connecticut) · Cited by 1
Hanessian, S. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527676545.ch16
der Naturwissenschaften, D. (2013)
The Specificity and Regulation of Human Histone Deacetylase 8.
Pitcairn, C. A. (2015) · Deep Blue (University of Michigan)
Target Identification of HDAC8 Isoform for the Treatment of Cancer
Umamaheswari, A., Puratchikody, A., & Balasubramaniyan, S. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-7326-5.ch007
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Sehr, P. A., Gunkel, N., Miller, A. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12440096 · Cited by 2
Hispidulin: a potential alternative to vorinostat against HDAC1 for acute myeloid leukemia
Balaji, S., Anbarasu, S., Ramaiah, S., & Anbarasu, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-03182-y
“Hence, ASP99 which is at the start of the catalytic cavity is important for optimum positioning of the ligand [83].”
Linarès, A. (2011) · theses.fr (ABES) · doi:10.70675/b58d4038z85d2z4a6fza2b6z64e5e5b158c3
Etude structurale du complexe de remodelage de la chromatine NuRD et sa sous-unité MBD3 liée à l'ADN
Tabaroni, R. (2018) · theses.fr (ABES) · doi:10.70675/7ad702abz74c7z45a9z9ecdz6aff4ba871ad
“De plus, toutes les enzymes de ces classes présentent également une topologie similaire composée d’un repliement α/β ainsi que d’un feuillet β de 8 brins parallèles (Lauffer et al., 2013) (Vannini et al., 2007) (Dowling et al., 2008) (Schuetz et al., 2008).”
Ramos‐Morales, E. (2021) · theses.fr (ABES) · doi:10.70675/c6b28473zf6b6z4024z99bfz05629f0484d7
Antypenko, L., Antypenko, O., Kozak, Y., Саліонов, В. О., Maletskyi, M., Лисянська, Г. П., & Kovalenko, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10243724/v1
Structural and Enzymatic Basis for Impaired Deacylation of N‑Acyl‑N‑Methyl Lysine Residues
Hilscher, S., Böttcher, P. H., Friedrich, F., Pannek, M., Baselious, F., Meleshin, M., Einsle, O., Bařinka, C., Steegborn, C., Sippl, W., et al. (2026) · Biochemistry · doi:10.1021/acs.biochem.6c00508 · Cited by 1
Costanzo, L. D., Christianson, D. W., & D'Antonio, E. L. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.09.004
BindingDB Entry 50010822: Environment-sensitive fluorescent inhibitors of histone deacetylase.
BindingDB (2021) · UC San Diego · doi:10.7270/q2tf01wm
BindingDB (2017) · UC San Diego · doi:10.7270/q2s184fm
BindingDB (2016) · UC San Diego · doi:10.7270/q2th8kh1
BindingDB Entry 50031855: Inside HDAC with HDAC inhibitors.
BindingDB (2010) · UC San Diego · doi:10.7270/q2br8scs
BindingDB (2011) · UC San Diego · doi:10.7270/q22b8z8w
BindingDB (2012) · UC San Diego · doi:10.7270/q24t6k81
BindingDB (2011) · UC San Diego · doi:10.7270/q28g8kzj
Conformational Variability: Implications for Biomolecular Activity and in Drug Design
Bhattacharyya, M. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Metadata
- Authors
- Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S.
- Affiliations
- Institute of Molecular Biology and Pathology (IT)
- Venue
- The EMBO Reports
- Published
- 2007-08-10
- Volume
- 8
- Issue
- 9
- Pages
- 879-884
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1973954
- OpenAlex
- W2164806419
- Cited by
- 256
- References
- 27
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 13 · 2019: 16 · 2018: 14 · 2017: 18 · 2016: 21 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 17
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
- Keywords
- HDAC8, substrate binding, active site residues, hydroxamate inhibitors, substrate recognition, catalytically inactive mutant, histone deacetylase inhibitors
- MeSH terms
- Aspartic Acid, Enzyme Inhibitors, Histone Deacetylases, Humans, Models, Molecular, Repressor Proteins, Structure-Activity Relationship, Substrate Specificity, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.